| Identification | Back Directory | [Name]
PalBociclib Impurity 23 | [CAS]
2205035-04-5 | [Synonyms]
PalBociclib Impurity 23
Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-[[3-(1-piperazinyl)-2-pyridinyl]amino]- | [Molecular Formula]
C24H29N7O2 | [MOL File]
2205035-04-5.mol | [Molecular Weight]
447.53 |
| Hazard Information | Back Directory | [Uses]
Palbociclib Impurity A is related to the parent compound, Palbocicib (P139900) (also known as compound number PD-0332991), which is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.Also, it is derived from 3-Fluoro-2-nitropyridine (F597685). |
|
|